202 related articles for article (PubMed ID: 16038719)
1. Identification of a novel immunodominant cytotoxic T lymphocyte epitope derived from human factor VIII in a murine model of hemophilia A.
Wang W; Merchlinsky M; Inman J; Golding B
Thromb Res; 2005; 116(4):335-44. PubMed ID: 16038719
[TBL] [Abstract][Full Text] [Related]
2. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M
Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693
[TBL] [Abstract][Full Text] [Related]
7. Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.
Rutigliano JA; Rock MT; Johnson AK; Crowe JE; Graham BS
Virology; 2005 Jul; 337(2):335-43. PubMed ID: 15916793
[TBL] [Abstract][Full Text] [Related]
8. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A.
Reipert BM; Ahmad RU; Turecek PL; Schwarz HP
Thromb Haemost; 2000 Nov; 84(5):826-32. PubMed ID: 11127864
[TBL] [Abstract][Full Text] [Related]
9. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
[TBL] [Abstract][Full Text] [Related]
10. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of the immune response to human factor VIII in murine hemophilia A.
Wu H; Reding M; Qian J; Okita DK; Parker E; Lollar P; Hoyer LW; Conti-Fine BM
Thromb Haemost; 2001 Jan; 85(1):125-33. PubMed ID: 11204564
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
[TBL] [Abstract][Full Text] [Related]
13. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor.
Sugihara T; Takahashi I; Kojima T; Okamoto Y; Yamamoto K; Kamiya T; Matsushita T; Saito H
Nagoya J Med Sci; 2000 May; 63(1-2):25-39. PubMed ID: 10911718
[TBL] [Abstract][Full Text] [Related]
14. Immunobiology of inhibitor development in hemophilia A.
Fijnvandraat K; Bril WS; Voorberg J
Semin Thromb Hemost; 2003 Feb; 29(1):61-8. PubMed ID: 12640567
[TBL] [Abstract][Full Text] [Related]
15. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy.
Chen J; Wu Q; Yang P; Hsu HC; Mountz JD
Mol Ther; 2006 Feb; 13(2):260-9. PubMed ID: 16324888
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor and transforming growth factor-beta modulate immune response against coagulation factor VIII in FVIII-deficient mice.
Kallas A; Kuuse S; Maimets T; Pooga M
Thromb Res; 2007; 120(6):911-9. PubMed ID: 17376515
[TBL] [Abstract][Full Text] [Related]
17. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.
Pratt KP; Qian J; Ellaban E; Okita DK; Diethelm-Okita BM; Conti-Fine B; Scott DW
Thromb Haemost; 2004 Sep; 92(3):522-8. PubMed ID: 15351848
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antibodies to factor VIII in hemophilia A patients treated by immune tolerance therapy.
Scandella D; Reyes H; Felch M; Sakurai Y
Haematologica; 2000 Oct; 85(10 Suppl):86-8. PubMed ID: 11187882
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring CD4+ CD25+ cells in modulating immune response to administered coagulation factor VIII in factor VIII-deficient mice.
Kallas A; Kuuse S; Maimets T; Pooga M
Haemophilia; 2011 Jan; 17(1):143-51. PubMed ID: 20731724
[TBL] [Abstract][Full Text] [Related]
20. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]